BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21057040)

  • 1. Suppression of PKG by PDGF or nitric oxide in differentiated aortic smooth muscle cells: obligatory role of protein tyrosine phosphatase 1B.
    Zhuang D; Balani P; Pu Q; Thakran S; Hassid A
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H57-63. PubMed ID: 21057040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.
    Pu Q; Zhuang D; Thakran S; Hassid A
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H101-8. PubMed ID: 21037226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.
    Zhuang D; Pu Q; Ceacareanu B; Chang Y; Dixit M; Hassid A
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H163-73. PubMed ID: 18456732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
    Sreejayan N; Lin Y; Hassid A
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1086-92. PubMed ID: 12117721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility.
    Zhuang D; Ceacareanu AC; Ceacareanu B; Hassid A
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1859-66. PubMed ID: 15576431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells.
    Browner NC; Sellak H; Lincoln TM
    Am J Physiol Cell Physiol; 2004 Jul; 287(1):C88-96. PubMed ID: 14985234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP specifically suppresses Type-Ialpha cGMP-dependent protein kinase expression by ubiquitination.
    Dey NB; Busch JL; Francis SH; Corbin JD; Lincoln TM
    Cell Signal; 2009 Jun; 21(6):859-66. PubMed ID: 19168131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.
    Yang HM; Kim BK; Kim JY; Kwon YW; Jin S; Lee JE; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Exp Mol Med; 2013 Nov; 45(11):e65. PubMed ID: 24287871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-{beta} activity in vascular smooth muscle cells.
    Wang S; Lincoln TM; Murphy-Ullrich JE
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1188-97. PubMed ID: 20164378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with insulin uncovers the motogenic capacity of nitric oxide in aortic smooth muscle cells: dependence on Gab1 and Gab1-SHP2 association.
    Dixit M; Zhuang D; Ceacareanu B; Hassid A
    Circ Res; 2003 Nov; 93(10):e113-23. PubMed ID: 14551245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1 transcription factor as a molecular target for nitric oxide-- and cyclic nucleotide--mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells.
    Sellak H; Yang X; Cao X; Cornwell T; Soff GA; Lincoln T
    Circ Res; 2002 Mar; 90(4):405-12. PubMed ID: 11884369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk.
    Lin Y; Ceacareanu AC; Hassid A
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H710-21. PubMed ID: 12714323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin upregulates cGMP-dependent protein kinase type Iβ through C/EBP transcription factor activation in contractile cells.
    Chamorro-Jorganes A; Calleros L; Griera M; Saura M; Luengo A; Rodriguez-Puyol D; Rodriguez-Puyol M
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C683-91. PubMed ID: 21160032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5.
    Usui S; Sugimoto N; Takuwa N; Sakagami S; Takata S; Kaneko S; Takuwa Y
    J Biol Chem; 2004 Mar; 279(13):12300-11. PubMed ID: 14711826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase G activity prevents pathological-level nitric oxide-induced apoptosis and promotes DNA synthesis/cell proliferation in vascular smooth muscle cells.
    Wong JC; Fiscus RR
    Cardiovasc Pathol; 2010; 19(6):e221-31. PubMed ID: 20060325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs.
    Jacob A; Molkentin JD; Smolenski A; Lohmann SM; Begum N
    Am J Physiol Cell Physiol; 2002 Sep; 283(3):C704-13. PubMed ID: 12176727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cells.
    Kibbe MR; Nie S; Seol DW; Kovesdi I; Lizonova A; Makaroun M; Billiar TR; Tzeng E
    J Vasc Surg; 2000 Feb; 31(2):364-74. PubMed ID: 10664504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation.
    Sauzeau V; Rolli-Derkinderen M; Marionneau C; Loirand G; Pacaud P
    J Biol Chem; 2003 Mar; 278(11):9472-80. PubMed ID: 12524425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.